Category: Cardiometabolic Disease

The rising costs of insulin continue to be a pressing issue for millions of Americans living with diabetes. In a recent development, a bipartisan group of

Novo Nordisk is set to launch a new subscription plan for its weight loss drug, Wegovy, aimed at self pay patients in the United States. This initiative

Eli Lilly has captivated the market with its recent FDA approval of a new weight loss medication, Foundayo. This development has not only elevated the

Protein powders offer a convenient solution for individuals seeking to fulfill their daily protein needs and maintain a balanced diet. However, the market

Chronic kidney disease (CKD) presents significant challenges in patient management, particularly in risk stratification and personalized treatment. Recent

Recent research from Vanderbilt University highlights a concerning link between high sodium consumption and increased heart failure risks. The study

In the evolving landscape of cardiology, recent findings suggest a significant shift in how we approach the long term management of patients following a

Nails serve as more than just aesthetic features; they can provide significant insights into your overall health. Changes in colour, shape, and texture

The increasing prevalence of heart failure in India presents a dual challenge: a medical crisis marked by rising patient numbers and a financial strain

Energy is the lifeblood of all biological processes. When energy production falters, it can lead to a cascade of health issues, including heart failure,

The recent approval of Foundayo by the Food and Drug Administration marks a significant milestone in the fight against obesity. Developed by Eli Lilly,

The relationship between glycemia, starch, and sugar is a critical aspect of nutrition and health. Understanding how these components interact can pave

Pharmaceutical stocks are gaining momentum as companies focus on advancing their drug pipelines, managing patent expirations, and engaging in strategic

The nutritional label on food packaging is designed to guide consumers in making informed dietary choices. However, a recent class action lawsuit

The FDA has granted rapid approval for Eli Lilly’s new weight loss medication, orforglipron, marketed under the name Foundayo. This addition to the

The 2026 Specialty Matching Service results illuminate the current dynamics within cardiology, showcasing a sector marked by distinct disparities. While

Recombinant protein expression has revolutionized the fields of biotechnology and medicine, playing a pivotal role in the development of therapeutic

Eli Lilly has made a significant stride in the obesity treatment landscape with the recent approval of its oral medication, orforglipron, also known as

Understanding diabetes has evolved significantly since its early characterization as a “sugar disease.” The initial observations of sweet tasting urine

The heart serves as a focal point in understanding the interplay between hormones and cardiovascular health. Cardiologists, oncologists, and

Sun Pharmaceutical Industries Limited has launched an impactful initiative titled ‘Heart ke Liye 8 – Making India Heart Strong.’ This campaign aims to

The United Kingdom’s drug cost effectiveness authority has made a significant recommendation regarding Novo Nordisk’s Wegovy, identifying it as a valuable

The female microbiome is shaped by various lifestyle factors that can significantly influence health outcomes. Recent research has delved into how diet,

The quest for an effective oral insulin treatment has long been a focal point in diabetes research. Recent breakthroughs from a dedicated team of

The quest for innovative solutions to diabetes management has taken a promising turn with the development of a groundbreaking implant. This small device,

Gan & Lee Pharmaceuticals has made significant strides in diabetes care with its once weekly basal insulin, GZR4 Injection. This innovative therapy has

The gut microbiome plays a critical role in maintaining metabolic health, acting as a complex ecosystem that influences various bodily functions. Recent

Sun Pharmaceutical Industries Limited has launched an inspiring campaign titled ‘HeartkeLiye8 – Making India Heart Strong.’ This initiative encourages

Novo Nordisk A/S is taking decisive action in the Indian pharmaceutical market by significantly reducing the prices of its popular diabetes and weight

Wave Life Sciences has recently released promising data regarding its non incretin therapy for weight loss, yet the market reaction has been tepid. The

Mayo Clinic researchers have unveiled a groundbreaking approach to enhancing cardiovascular disease risk predictions through artificial intelligence (AI).

Polycystic ovarian syndrome (PCOS) affects a significant number of women in their reproductive years, often leading to hormonal imbalances and metabolic

The integration of nutrition into medical education has become a vital necessity. Recent updates in dietary guidelines highlight a growing recognition of

Living with chronic lung diseases can significantly impact daily life. For individuals and caregivers alike, understanding how nutrition influences lung

March marks National Nutrition Month, a time dedicated to enhancing our well being through mindful eating and healthier lifestyle choices. For the

Understanding metabolism has become increasingly important in discussions about weight loss and overall health. Amidst a flurry of trendy diets and

In the United States, the prevalence of Type 2 diabetes is alarming, with over 40 million adults diagnosed and another 11 million unaware they are

In a groundbreaking development, gene modified pancreas cells have emerged as a potential game changer for patients suffering from type 1 diabetes (T1D).

High cortisol levels can often be an invisible burden, subtly affecting your health and well being without clear warning signs. This stress hormone plays

This article explores a significant case of a 34 year old woman suffering from severe refractory mast cell activation syndrome (MCAS), despite normal

KACTUS, a biotechnology company based in Waltham, Massachusetts, has launched a new line of ultra low endotoxin recombinant human kallikrein 1 (KLK1)

Eli Lilly & Co. is making waves in the pharmaceutical industry, particularly in the obesity and diabetes treatment markets. With an impressive track

Eli Lilly has made a significant advancement in employee healthcare by launching Employer Connect, a platform that facilitates better access to obesity